Physician
Otolaryngology (ENT)
Grant Rohman, MD is an expert in the field of Otolaryngology (ENT). He went to medical school at East Tennessee State University James H. Quillen College of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Grant Rohman, MD is also published. He has 5 publications published. The lastest publication: "Head and neck manifestations of langerhan's cell histiocytosis in children: A 46-year experience.' He is registered with Medicare and accepts Medicare payments.
Publications
Procedures Preformed
- Ablation or Excision of Nasal Turbinates
- Antrostomy and Antrotomy (Sinus Surgery)
- Balloon Sinuplasty
- Cochlear Implant Insertion
- View All
Conditions Treated
- Acute Laryngitis
- Acute Sinusitis
- Acute Tonsillitis
- Allergic Rhinitis
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
- Aetna
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Tennessee
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Special Needs Plan SNP
- MultiPlan
- POMCO Group
- TriCare for Life
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Tennessee
-
East Tennessee State University James H. Quillen College of Medicine
Drug Facts
NPI NUMBER |
|
1356542476 |
NPPES Provider LastName |
|
ROHMAN |
NPPES Provider FirstName |
|
GRANT |
NPPES Provider ZIPCode |
|
385012452 |
NPPES Provider State |
|
TN |
Specialty Description |
|
Otolaryngology |
Total Claim Count |
|
355.0 |
Distinct Opioid Count |
|
2.0 |
Opioid Claim Count |
|
40.0 |
Percent Opioid Claims |
|
11.27 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1356542476 |
Last Name Of The Provider |
ROHMAN |
First Name Of The Provider |
GRANT |
View All |
|
Doctor Directory | TOS | twitter | FB | Angel | blog